Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High-risk HPV DNA testing and HPV-16/18 genotyping: what is the clinical application?

Journal of lower genital tract disease - 1 Jul 2011

Twiggs Leo B, Hopkins Michael

Abstract excerpt

OBJECTIVE: There are currently 2 tests approved for clinical use that nonspecifically detect the presence of multiple oncogenic or high-risk human papillomavirus (HPV) types. One HPV genotyping test is also available for use that specifically detects the presence of high-risk HPV types 16 and 18. The purpose of this review was to evaluate the clinical performance of these HPV DNA tests and the utility of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cervix Uteri
Share to Human papillomavirus 16
Share to Human papillomavirus 18

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Molecular Diagnostic Techniques

Share to Papillomavirus Infections

Share to Precancerous Conditions

Share to Uterine Cervical Neoplasms

Share to Vaginal Smears

Source

Identifiers

PMID: 21716051
DOI: 10.1097/LGT.0b013e3181fb46d8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High-risk HPV DNA testing and HPV-16/18 genotyping: what is the clinical application?PMID 21716051Read ↗

Retrospective analysis of HPV infection: Cotesting and HPV genotyping in cervical cancer screening within a large academic health care system.Semantic proximity Read ↗

Evaluation of clinical usefulness of HPV-16 and HPV-18 genotyping for cervical cancer screening.Semantic proximity Read ↗

Clinical significance of human papillomavirus genotyping.Semantic proximity Read ↗

Colposcopic Biopsy Findings in ASCUS or Normal Cervical Cytology Patients with High-Risk HPV PositivitySemantic proximity Read ↗

Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results.Semantic proximity Read ↗

Genotype profile of HPV in ASC-H cytology and histologic follow-up-prevalence, distribution, and risk: A retrospective study of 1414 cases.Semantic proximity Read ↗

2013 Statement on Human Papillomavirus DNA Test UtilizationSemantic proximity Read ↗

Clinical significance of extended high-risk human papillomavirus genotyping and viral load in cervical cancer and precancerous lesionsSemantic proximity Read ↗

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.Semantic proximity Read ↗

High-Risk HPV Genotype Distribution According to Cervical Cytology and AgeSemantic proximity Read ↗

High-risk human papillomavirus genotyping in women with atypical squamous cells of undetermined significance.Semantic proximity Read ↗

Molecular tests potentially improving HPV screening and genotyping for cervical cancer preventionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.